Alnylam Pharmaceuticals
ALNY
#786
Rank
A$45.01 B
Marketcap
A$336.39
Share price
-2.42%
Change (1 day)
-51.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company